Your browser doesn't support javascript.
loading
Topoisomerase 2ß mutation impairs early B-cell development.
Papapietro, Olivier; Chandra, Anita; Eletto, Davide; Inglott, Sarah; Plagnol, Vincent; Curtis, James; Maes, Mailis; Alisaac, Ali; Albuquerque, Adriana S; Basseres, Eugenie; Hermine, Olivier; Picard, Capucine; Fischer, Alain; Durandy, Anne; Kracker, Sven; Burns, Siobhan O; Cuchet-Lourenco, Delphine; Okkenhaug, Klaus; Nejentsev, Sergey.
Affiliation
  • Papapietro O; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Chandra A; Department of Molecular Cell Biology and Immunology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
  • Eletto D; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Inglott S; Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, United Kingdom.
  • Plagnol V; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Curtis J; Great Ormond Street Hospital National Health Service Trust, London, United Kingdom.
  • Maes M; University College London Genetics Institute, London, United Kingdom.
  • Alisaac A; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Albuquerque AS; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Basseres E; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Hermine O; College of Applied Sciences, Al Baha University, Al Baha, Saudi Arabia.
  • Picard C; University College London Institute of Immunity and Transplantation, London, United Kingdom.
  • Fischer A; Department of Molecular Cell Biology and Immunology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
  • Durandy A; Imagine Institute, University Paris Descartes Sorbonne Paris Cité, Paris, France.
  • Kracker S; INSERM UMR 1163, Paris, France.
  • Burns SO; INSERM UMR 1163, Paris, France.
  • Cuchet-Lourenco D; Study Center for Primary Immunodeficiencies, Assistance Publique-Hôpitaux de Paris, Necker Hospital, Paris, France.
  • Okkenhaug K; Department of Pediatric Immunology, Hematology and Rheumatology, Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Nejentsev S; Imagine Institute, University Paris Descartes Sorbonne Paris Cité, Paris, France.
Blood ; 135(17): 1497-1501, 2020 04 23.
Article in En | MEDLINE | ID: mdl-32128574
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: B-Lymphocytes / DNA Topoisomerases, Type II / Poly-ADP-Ribose Binding Proteins / Hematopoiesis / Immunologic Deficiency Syndromes / Mutation Type of study: Prognostic_studies Limits: Female / Humans / Male Language: En Journal: Blood Year: 2020 Document type: Article Affiliation country: United kingdom Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: B-Lymphocytes / DNA Topoisomerases, Type II / Poly-ADP-Ribose Binding Proteins / Hematopoiesis / Immunologic Deficiency Syndromes / Mutation Type of study: Prognostic_studies Limits: Female / Humans / Male Language: En Journal: Blood Year: 2020 Document type: Article Affiliation country: United kingdom Country of publication: United States